Benitec Biopharma Inc.

(BNTC) Trade

By |

Profile

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV).

Contact Information

Website: www.benitec.com
Main Phone: +1 510 780-0819
Address: 3940 Trust Way
Address 2: Level 14
State: CA
City / Town: Hayward
Country: US
Postal Code: 94545

Issuer Information

Exchange: NSC
CEO: Jerel A. Banks
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV).

Contact Information

Website: www.benitec.com
Main Phone: +1 510 780-0819
Address: 3940 Trust Way
Address 2: Level 14
State: CA
City / Town: Hayward
Country: US
Postal Code: 94545

Issuer Information

Exchange: NSC
CEO: Jerel A. Banks
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 2.90 $ 0. (0.00%)
Last Price 2.90 Change $ 0. Change % 0.00 Tick N/A
Bid 2.76 Bid Size 600.00 Ask 3.19 Ask Size 700.00
Open 2.97 High 2.97 Low 2.78 Prev Close 2.90
Last Trade Volume 71,386 52 Wk Hi 17.42 52 Wk Low 2.75
Market Cap 12.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 4,405,469.00 EPS (TTM) -8.10 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 14 14 14 14
Low Target Price Estimate 14 14 14 14
Mean Target Price Estimate 14 14 14 14
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 02/24/16 02/24/16 02/24/16 02/24/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3